127 related articles for article (PubMed ID: 30309878)
1. Hyperviscosity syndrome in splenic marginal zone lymphoma.
Daniel R; Chan RY
Blood; 2018 Oct; 132(15):1627. PubMed ID: 30309878
[No Abstract] [Full Text] [Related]
2. Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.
Pata G; Damiani E; Bartoli M; Solari S; Anastasia A; Pagani C; Tucci A; Ragni F
Leuk Lymphoma; 2016; 57(6):1467-70. PubMed ID: 26373930
[No Abstract] [Full Text] [Related]
3. Bone marrow-derived mesenchymal stem/stromal cells from patients with splenic marginal zone lymphoma are intrinsically impaired and influence the malignant B-cells.
Pontikoglou C; Kalyva A; Kalpadakis C; Velegraki M; Bizymi N; Alpantaki K; Kontakis G; Pangalis GA; Papadaki HA
Leuk Lymphoma; 2019 Feb; 60(2):538-540. PubMed ID: 29966468
[No Abstract] [Full Text] [Related]
4. Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis.
Cagliuso M; Conti V; Trasarti S; Lombardi L; Riminucci M; Perez M; Turriziani O; Falasca F; Nanni M; Tafuri A; Mezzaroma I
Infection; 2013 Feb; 41(1):255-8. PubMed ID: 23007326
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL.
Favre R; Manzoni D; Traverse-Glehen A; Verney A; Jallades L; Callet-Bauchu E; Sujobert P; Salles G; Baseggio L
Int J Lab Hematol; 2018 Aug; 40(4):e59-e62. PubMed ID: 29659173
[No Abstract] [Full Text] [Related]
6. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
7. NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
Alderuccio JP; Lossos IS
Leuk Lymphoma; 2022 Feb; 63(2):279-290. PubMed ID: 34586000
[TBL] [Abstract][Full Text] [Related]
8. Splenic marginal zone lymphoma leads to sinistral portal hypertension.
Lv XH; Ma LL; Fu WY; Xie Y
J Dig Dis; 2019 Jan; 20(1):45-48. PubMed ID: 30549195
[No Abstract] [Full Text] [Related]
9. Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years.
Carr JA
Can J Gastroenterol; 2012 Mar; 26(3):123-4. PubMed ID: 22462122
[No Abstract] [Full Text] [Related]
10. Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.
Montalban C; Abraira V; Arcaini L; Domingo-Domenech E; Guisado-Vasco P; Iannitto E; Mollejo M; Matutes E; Ferreri AJ; Salar A; Rattotti S; Carpaneto A; Perez R; Bello JL; Hernandez M; Caballero D; Carbonell F; Piris MA;
Leuk Lymphoma; 2014 Apr; 55(4):929-31. PubMed ID: 23799931
[No Abstract] [Full Text] [Related]
11. Remission of splenic marginal zone lymphoma in a patient treated for hepatitis B: a case of HBV-associated lymphoma.
Koot AW; Visscher AP; Huits RM
Acta Clin Belg; 2015 Aug; 70(4):301-3. PubMed ID: 25977147
[TBL] [Abstract][Full Text] [Related]
12. A peculiar case of splenic marginal zone lymphoma and review of literature.
Mishra MN; Pandey R; Dinda A; Nityanand S
Iran J Immunol; 2013 Sep; 10(3):186-9. PubMed ID: 24076596
[No Abstract] [Full Text] [Related]
13. Management of marginal zone lymphoma.
Reid R; Friedberg JW
Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
[No Abstract] [Full Text] [Related]
14. Clinical and biological diversity of splenic marginal zone lymphoma.
Matutes E
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
[No Abstract] [Full Text] [Related]
15. Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Vase MØ; Hellberg YK; Larsen CS; Petersen E; Schaumburg H; Bendix K; Ravel C; Bastien P; Christensen M; d'Amore F
Acta Haematol; 2012; 128(1):20-2. PubMed ID: 22572474
[No Abstract] [Full Text] [Related]
16. Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema.
Motosue MS; Howard MT; Butterfield JH
Ann Allergy Asthma Immunol; 2016 May; 116(5):472-3. PubMed ID: 27017557
[No Abstract] [Full Text] [Related]
17. Clinical and diagnostic relevance of
Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
[No Abstract] [Full Text] [Related]
18. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
Robinson AC; Nachar VR
J Oncol Pharm Pract; 2020 Jul; 26(5):1248-1253. PubMed ID: 31766968
[TBL] [Abstract][Full Text] [Related]
19. [49-year-old woman with leukocytosis and splenomegaly].
Austein T; Meinecke G
Dtsch Med Wochenschr; 2011 Oct; 136(43):2197-8. PubMed ID: 22009173
[No Abstract] [Full Text] [Related]
20. Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.
Komeno Y; Shibuya N; Uryu H; Yamada H; Toda T; Shibasaki M; Kunishima S; Iihara K; Ryu T
Intern Med; 2017; 56(5):557-562. PubMed ID: 28250305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]